Eribulin Mesylate in Treating Patients With Advanced or Recurrent Cervical Cancer
by on Friday, August 31st, 2012 | No Comments
Conditions: Recurrent Cervical Cancer; Stage IIIA Cervical Cancer; Stage IIIB Cervical Cancer; Stage IVA Cervical Cancer; Stage IVB Cervical Cancer
Intervention: Drug: eribulin mesylate
Sponsors: USC/Norris Comprehensive Cancer Center; USC/Norris Comprehensive Cancer Center; National Cancer Institute (NCI)
Recruiting – verified August 2012
Read the rest here: Eribulin Mesylate in Treating Patients With Advanced or Recurrent Cervical Cancer